Chemicals & Health. Report of the Panel on Chemicals and Health of the President's Science Advisory Committee, Science and Technology Policy Office, National Science Foundation, Sept. 1973, p. 23.
2.
TalleyR. B.LaventurierM. F.: Drug utilization and peer review in San Joaquin. Presented before the American Association of Foundations for Medical Care, Sea Island, Georgia, Aug. 28, 1972.
3.
Hearings Before Senate Subcommittee on Health of the Committee on Labor and Public Health. Feb. 22, 1973.
4.
National Enquirer. May 6, 1973, p. 5.
5.
Hearings: op. cit. Dec. 18, 1973.
6.
TalleyR. B.LaventurierM. F.: Drug-induced illness, JAMA229: 1043, Aug. 19, 1974.
7.
SilvermanM.LeeP. R.: Pills, Profits & Politics. University of California Press, Berkely, 1974, p. 264.
8.
ShapiroS.SloneD.LewisG.JickH.: Fatal drug reactions among medical inpatients, JAMA216:467–472, 1971.
9.
RuckerT. D.: Economic aspects of drug overuse. Presented at Medical Society of D.C. Drug Symposium, May 15, 1973.
10.
MelmonK. L.: Preventable drug reactions: Causes and curesN. Engl. J. Med.284: 1361–1368, 1971.
11.
Hearings: op. cit. Feb. 28, 1974.
12.
CaranasosG. J.StewartR. B.CluffL. E.: Drug-induced illness leading to hospitalization, JAMA228:713–717, 1974.
13.
MillerR. R.: Drug surveillance utilizing epidemiologic methods: A report from the Boston Collaborative Drug Surveillance Program, Am. J. Hosp. Pharm. p. 584–592, 1973.
14.
SmidtN. A.McQueenE. G.: Adverse reactions to drugs: A comprehensive hospital inpatient survey, NZ Med. J.76: 397–401, 1972.
15.
HurwitzN.WadeO. L.: Intensive hospital monitoring of adverse reactions to drugs, Br. Med. J.1: 531–536, 1969.
16.
OgilvieR. I.RuedyJ.: Adverse drug reactions during hospitalization, Can. Med. Assoc. J.97: 1450–1457, 1967.
17.
Anonymous.: The doctor behind Ralph Nader, Med. World News, June 7, 1974, p. 43.